SHOULDER & ELBOW
AAOS2017: Continuous vs. single-shot interscalene block after shoulder arthroplasty
76 patients scheduled for shoulder arthroplasty were randomized to postoperative analgesia with either a continuous or single-shot interscalene block. Patients were assessed for pain, opioid consumption, the length of stay, and the incidence of adverse events. In addition, patients who were administered continuous infusion were monitored for rate of catheter withdrawal. Results demonstrated significantly lower pain scores on the first postoperative day in the continuous group compared to the single-shot group, but no significant differences at other time points. Opioid consumption was also significantly lower in the continuous group compared to the single-shot group. There were no significant differences between groups for the length of stay or adverse events.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
